Literature DB >> 24655107

Factors associated with influenza vaccination among adult cancer patients: a case-control study.

I Vinograd1, R Baslo, N Eliakim-Raz, L Farbman, A Taha, A Sakhnini, A Lador, S M Stemmer, A Gafter-Gvili, D Fraser, L Leibovici, M Paul.   

Abstract

Influenza vaccination is recommended for cancer patients; however, adherence is low. We aimed to identify predictive factors for vaccination among cancer patients. We conducted a case-control analysis of a patient cohort in the 2010-2011 influenza season. We included adult cancer patients with solid malignancies undergoing chemotherapy, and haematological patients with active disease. Patients who died between October and November 2010 (N = 43) were excluded from analysis. Cases received the 2011 seasonal influenza vaccine, and controls did not. Data were obtained from patients' records, and validated through personal interviews. We collected socio-demographic information, and data on the malignancy and co-morbidities and triggers for vaccination and non-vaccination. We performed bivariate and multivariable analyses, in which vaccination status was the dependent variable. Of 806 patients included in analysis, 387 (48%) were vaccinated. Variables associated with vaccination on bivariate analysis were older age, higher socio-economic status, lower crowding index, marital status (widowed > married > single), malignancy type (haematological > solid tumours) and time from diagnosis, low-risk malignancy, diabetes, past vaccination, country of birth (non-Russian origin), and physicians' recommendations. Predictive factors found to be independently associated with vaccination on multivariable analysis were past vaccinations, low-risk malignancy, and country of birth. In the analysis conducted among interviewees (N = 561), recommendations from the oncologist (OR 10.7, 95% CI 5.4-21.2) and from the primary-care physician (OR 3.35, 95% CI 2.05-5.49) were strong predictors for vaccination. We conclude that 'habitual vaccinees' continue influenza vaccinations when ill with cancer. Physicians' recommendations, especially the oncologist's, have a major influence on patients' compliance with influenza vaccination.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Adherence; chemotherapy; influenza; neoplasm; vaccine

Mesh:

Substances:

Year:  2014        PMID: 24655107     DOI: 10.1111/1469-0691.12625

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  11 in total

Review 1.  Seasonal influenza vaccine in immunocompromised persons.

Authors:  Mohammad Bosaeed; Deepali Kumar
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

2.  Vaccination in oncology practice and predictors.

Authors:  Ali Alkan; Ebru Karcı; Arzu Yaşar; Gülseren Tuncay; Elif Berna Köksoy; Muslih Ürün; Filiz Çay Şenler; Ahmet Demirkazık; Güngör Utkan; Hakan Akbulut; Yüksel Ürün
Journal:  Support Care Cancer       Date:  2017-03-22       Impact factor: 3.603

3.  Influenza vaccination uptake and attitudes among adult cancer patients in Japan: a web-based questionnaire survey before the 2020/2021 season.

Authors:  Makoto Kosaka; Yasuhiro Kotera; Kenji Tsuda; Kenzo Takahashi; Tamae Hamaki; Eiji Kusumi; Masahiro Kami; Tetsuya Tanimoto
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

4.  Immunogenicity of Influenza Vaccination in Patients With Cancer.

Authors:  Saiama N Waqar; Leigh Boehmer; Daniel Morgensztern; Andrea Wang-Gillam; Steven Sorscher; Steven Lawrence; Feng Gao; Kalin Guebert; Kristina Williams; Ramaswamy Govindan
Journal:  Am J Clin Oncol       Date:  2018-03       Impact factor: 2.339

5.  Attitudes of Patients with Cancer towards Vaccinations-Results of Online Survey with Special Focus on the Vaccination against COVID-19.

Authors:  Anna Brodziak; Dawid Sigorski; Małgorzata Osmola; Michał Wilk; Angelika Gawlik-Urban; Joanna Kiszka; Katarzyna Machulska-Ciuraj; Paweł Sobczuk
Journal:  Vaccines (Basel)       Date:  2021-04-21

Review 6.  Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.

Authors:  Silvia Sánchez-Ramón; Fatima Dhalla; Helen Chapel
Journal:  Front Immunol       Date:  2016-08-22       Impact factor: 7.561

Review 7.  Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.

Authors:  Philipp Schmid; Dorothee Rauber; Cornelia Betsch; Gianni Lidolt; Marie-Luisa Denker
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

8.  Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.

Authors:  Paul D E Miller; Alice S Forster; Thushan I de Silva; Hayley Leonard; Chloe Anthias; Michaela Mayhew; Matthias Klammer; Susan Paskar; Erin Hurst; Karl Peggs; Alejandro Madrigal; John A Snowden
Journal:  BMJ Open       Date:  2018-08-08       Impact factor: 2.692

9.  Seasonal Influenza Vaccine: Uptake, Attitude, and Knowledge Among Patients Receiving Immunoglobulin Replacement Therapy.

Authors:  Fionnuala Cox; Catherine King; Anne Sloan; David J Edgar; Niall Conlon
Journal:  J Clin Immunol       Date:  2021-01-05       Impact factor: 8.317

10.  Influenza in hospitalised patients with malignancy: a propensity score matching analysis.

Authors:  Jiarui Li; Dingding Zhang; Zhao Sun; Chunmei Bai; Lin Zhao
Journal:  ESMO Open       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.